Friday - July 24, 2026
Biosimilars Council and AAM Applaud Senate Markup and Committee Passage of the Expedited Access to Biosimilars Act
July 24, 2026
WASHINGTON, July 24 -- The Association for Accessible Medicines issued the following news release:

* * *

Biosimilars Council and AAM Applaud Senate Markup and Committee Passage of the Expedited Access to Biosimilars Act

Legislation codifies FDA's science-based approach to biosimilar review by limiting comparative efficacy studies; Introduced and Passed House Committee This Week

-

The Biosimilars Council and the Association for . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products